Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05543889
Other study ID # JINA1001
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date December 7, 2022
Est. completion date March 7, 2024

Study information

Verified date December 2023
Source Moorfields Eye Hospital NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Increases in the aging population has resulted in increased demand for glaucoma services. Glaucoma is a disease that if untreated, can lead to blindness. This increase and need for long term treatment with monitoring have resulted in a significant demand in the hospital eye service (HES). Many departments are now facing a considerable backlog of outpatient appointments and it's essential that these appointments are reserved for patients who are at risk of glaucoma blindness. Primary angle closure (PAC) glaucoma is a type of glaucoma, where the drainage route for the fluid inside the eye (known as the angle) is narrowed or blocked. It has been recently identified that approximately half of patients referred into the HES for a suspect narrow angle for further investigation are healthy and are immediately discharged. The exact reasons for these findings are unknown. This project will investigate clinical decisions by community optometrists who account for the majority of PAC referrals into the HES, as well as assessing their ability to evaluate those at risk of PAC. This project will also examine whether clinical agreement could be improved by providing an educational package. A clinical image database of angles will be acquired from glaucoma patients attending Moorfields Eye Hospital. A learning package discussing angle closure referral will also be developed. Community optometrists will be invited to complete a questionnaire on their clinical decision making. This will be followed by the vignette assessment, learning package and re-assessment. If this educational package and/or any other identifiers are found to improve agreement levels, this could reduce the number of referrals and enable community monitoring of those at low risk of developing PAC glaucoma in their lifetime.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 163
Est. completion date March 7, 2024
Est. primary completion date March 7, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: New patients attending the glaucoma clinic at Moorfields Eye Hospital Exclusion Criteria: - They cannot be examined using a table mounted slit lamp due to physical limitations or have gross nystagmus. - Unable to consent - If they are unable to communicate in English and there is no available interpreter that meets requirements set out by Moorfields standard operating policies for patients - Under 18 years old

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Educational package
Online learning package that will discuss the van Herick technique, grading, accuracy and information and discusses the current guidelines for primary angle closure suspect referral.

Locations

Country Name City State
United Kingdom Moorfields Eye Hospital NHS Foundation Trust, 162 City Road London

Sponsors (1)

Lead Sponsor Collaborator
Moorfields Eye Hospital NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Agreement of community optometrists on measuring Limbal anterior chamber depth Levels of agreement and precision of optometrist observers before and after intervention of online educational package in assessment of Limbal anterior chamber depth as a surrogate measure of angle width. Agreement will be measured via an online assessment vignette assessment package. Weighted Kappa statistic and levels agreement will be the outcome measures 12 months
Secondary Qualitative outcome measures from optometrists Questionnaire based outcomes capturing data around current practice, qualifications and training, knowledge and resources available in practice with regards to angle closure diagnosis and referral 12 months
Secondary Qualitative outcome measures from patients Difficulty in performing tests and satisfaction from the appointment (Likert scale 1-10), time taken (minutes) and costs of travel (£) to test site and waiting time to be examined from referral (months). 12 months
See also
  Status Clinical Trial Phase
Completed NCT00350428 - Laser Iridotomy Versus Phacoemulsification in Acute Angle Closure N/A
Recruiting NCT03626675 - Anterior Segment Changes by Optical Coherence Tomography (OCT) in Phaco- Trabeculectomy N/A
Completed NCT01895686 - Comparison of Gonioscopy With Cirrus and Visante
Completed NCT02474238 - Comparing Nd:YAG Laser and Sequential Double Frequency YAG-Nd:YAG Laser Iridotomy N/A
Completed NCT02199158 - Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies N/A
Completed NCT00524758 - Oculusgen (Ologen) Glaucoma MMC Control in Estonia Phase 3
Active, not recruiting NCT04242108 - Diagnostic Performance of Deep Learning for Angle Closure
Completed NCT04476810 - Long Term Outcome of Combined Phacoemulsification and Excisional Goniotomy With the Kahook Dual Blade N/A
Active, not recruiting NCT05576493 - Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma N/A